Affinity DataKi: 1.30nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 2.10nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.40nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Compound was evaluated for inhibition of ThrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 4.70nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.80nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6.70nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6.70nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 7.70nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 8.30nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.10nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.20nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.40nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.90nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11.9nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibitory activity of the compound was tested against alpha-human thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Compound was evaluated for inhibition of ThrombinMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 14nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataKi: 22nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair